Stocks and Investing Stocks and Investing
Mon, January 7, 2019
[ 12:00 AM ] - United States, WOPRAI
James Faucette Upgraded (ANET) to Buy and Decreased Target to $63 on, Jan 7th, 2019
[ 12:00 AM ] - United States, WOPRAI
Joshua Shanker Maintained (CB) at Strong Sell with Decreased Target to $121 on, Jan 7th, 2019
[ 12:00 AM ] - United States, WOPRAI
Shahriar Pourreza Downgraded (AEP) to Hold on, Jan 7th, 2019
[ 12:00 AM ] - United States, WOPRAI
Brian Wieser Upgraded (ADBE) to Strong Buy and Increased Target to $262 on, Jan 7th, 2019
[ 12:00 AM ] - United States, WOPRAI
Matthew McClintock Upgraded (AAP) to Buy and Increased Target to $205 on, Jan 7th, 2019
[ 12:00 AM ] - United States, WOPRAI
Carlo Santarelli Maintained (VAC) at Hold with Decreased Target to $93 on, Jan 7th, 2019
[ 12:00 AM ] - United States, WOPRAI
Matthew Boss Downgraded (URBN) to Hold and Decreased Target to $38 on, Jan 7th, 2019
[ 12:00 AM ] - United States, WOPRAI
Meta Marshall Maintained (BAND) at Hold with Increased Target to $46 on, Jan 7th, 2019
[ 12:00 AM ] - United States, WOPRAI
Anthony Pettinari Maintained (BERY) at Strong Buy with Increased Target to $60 on, Jan 7th, 2019
Fri, January 4, 2019
[ 12:00 AM ] - United States, WOPRAI
David Leiker Downgraded (ALV) to Sell and Decreased Target to $64 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Mark Schappel Upgraded (AZPN) to Strong Buy on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
David Leiker Downgraded (VC) to Hold on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Walter Pritchard Maintained (AAPL) at Strong Buy with Decreased Target to $43 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Alexander Blostein Upgraded (ARES) to Strong Buy and Held Target at $23 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Initiated (ARGX) at Buy and Held Target at $140 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
David Leiker Downgraded (ADNT) to Sell and Decreased Target to $14 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Mitch Steves Downgraded (ADI) to Hold on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Steve Beuchaw Maintained (ALGN) at Hold with Decreased Target to $210 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Alexander Blostein Upgraded (CBOE) to Strong Buy and Held Target at $120 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Michael Cyprys Maintained (BX) at Buy with Decreased Target to $36 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Andrew Wittmann Maintained (UNF) at Buy with Decreased Target to $152 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Scott Gruber Maintained (WHD) at Strong Buy with Decreased Target to $41 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Scott Schrier Maintained (WMS) at Hold with Decreased Target to $27 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Michael Cyprys Maintained (BLK) at Buy with Decreased Target to $489 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Alexander Blostein Downgraded (TROW) to Hold and Held Target at $93 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Michael Cyprys Maintained (TROW) at Hold with Decreased Target to $98 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Vivek Arya Downgraded (TXN) to Hold on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Anthony Pettinari Maintained (SUM) at Strong Buy with Decreased Target to $18 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
John Lovallo Upgraded (AWI) to Strong Buy and Held Target at $75 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Kristen Stewart Downgraded (AVNS) to Sell and Decreased Target to $36 on, Jan 4th, 2019

Kristen Stewart Downgraded (AVNS) to Sell and Decreased Target to $36 on, Jan 4th, 2019


Published on 2024-10-26 11:31:42 - WOPRAI, Kristen Stewart
  Print publication without navigation


Kristen Stewart of Barclays, Downgraded "Avanos Medical, Inc." (AVNS) to Sell and Decreased Target from $59 to $36 on, Jan 4th, 2019.

Kristen has made no other calls on AVNS in the last 4 months.



There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, 0 agree with Kristen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Kristen

  • Matthew Mishan of "Keybanc" Maintained at Buy with Decreased Target to $67 on, Tuesday, December 18th, 2018

Contributing Sources